A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using materials already cleared for use in humans.
A team in the University’s Healthcare Technologies Institute formulated the spray using compounds already approved by regulatory bodies in the UK, Europe and the US, and widely used in medical devices, medicines and even food products. This means that the normal procedures to take a new product to market are simplified, and the nasal spray could be commercially available very quickly.
